LivaNova PLC (NAS:LIVN)
$ 52.52 0.21 (0.4%) Market Cap: 2.85 Bil Enterprise Value: 3.20 Bil PE Ratio: 0 PB Ratio: 2.29 GF Score: 70/100

LivaNova PLC at Barclays Global Healthcare Conference Transcript

Mar 16, 2023 / 01:00PM GMT
Release Date Price: $42.08 (+1.50%)
Matthew Stephan Miksic
Barclays Bank PLC, Research Division - Research Analyst

Good morning, Matt Miksic.And I cover U.S. medical devices here at Barclays. We're very pleased to have with us LivaNova. From the team, we've got Matt Dodds, Senior Vice President, Corporate Development; and Briana Gotlin, Director of IR. So thanks again, both of you for coming and taking the time to chat with us.

Matthew Joseph Dodds
LivaNova PLC - SVP of Corporate Development

No, Matt. Thanks for having us. And Damien sends his apologies, his knee gave out yesterday when we were in Houston. And I told them Matt's got 20-plus years of orthopedic experience, but it didn't get them over. But he apologizes for not being able to be here today with us.

Questions & Answers

Matthew Stephan Miksic
Barclays Bank PLC, Research Division - Research Analyst

No worries at all. So I thought maybe we start with sort of the clinical pipeline. And I know recover and difficult-to-treat depression has been kind of a -- to say it's been a big

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot